Thermal aggregation of human immunoglobulin G in arginine solutions: Contrasting effects of stabilizers and destabilizers.

Arginine is widely used as aggregation suppressor of proteins in biotechnology and pharmaceutics. However, why the effect of arginine depends on the types of proteins and stresses, including monoclonal antibodies, is still unclear. Here we investigated the precise processes of the thermal aggregation of human immunoglobulin G (IgG) in the presence of additives. As expected, arginine was the best additive to suppress the formation of insoluble aggregates during heat treatment, though it was unable to preserve the monomer content. A systematic analysis of the additives showed that sugars and kosmotropic ion inhibit the formation of soluble oligomers. These behaviors indicate that the thermal aggregation of IgG occurs by (i) the formation of soluble oligomers, which is triggered by the unfolding process that can be stabilized by typical osmolytes, and (ii) the formation of insoluble aggregates through weak cluster-cluster interactions, which can be suppressed by arginine. Understanding the detailed mechanism of arginine will provide useful information for the rational formulation design of antibodies.

[1]  T. Arakawa,et al.  Effect of additives on protein aggregation. , 2009, Current pharmaceutical biotechnology.

[2]  Vicki Sifniotis,et al.  The state‐of‐play and future of antibody therapeutics☆ , 2017, Advanced drug delivery reviews.

[3]  B. Trout,et al.  Interaction of arginine with proteins and the mechanism by which it inhibits aggregation. , 2010, The journal of physical chemistry. B.

[4]  S. N. Timasheff,et al.  Interactions of proteins with solvent components in 8 M urea. , 1981, Archives of biochemistry and biophysics.

[5]  Linda O. Narhi,et al.  Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies , 2009, Pharmaceutical Research.

[6]  K. Gekko,et al.  Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. , 1981, Biochemistry.

[7]  T. Arakawa,et al.  Mechanism of protein salting in and salting out by divalent cation salts: balance between hydration and salt binding. , 1984, Biochemistry.

[8]  Theodore W Randolph,et al.  Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. , 2009, Journal of pharmaceutical sciences.

[9]  C. Russell Middaugh,et al.  Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity , 2016, mAbs.

[10]  J. Carpenter,et al.  A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Bhat,et al.  Why Is Trehalose an Exceptional Protein Stabilizer? , 2003, Journal of Biological Chemistry.

[12]  T. Arakawa,et al.  Stabilization of protein structure by sugars. , 1982, Biochemistry.

[13]  L. Cavacini,et al.  Structure and function of immunoglobulins. , 2010, The Journal of allergy and clinical immunology.

[14]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[15]  M. Morbidelli,et al.  Aggregation Mechanism of an IgG2 and two IgG1 Monoclonal Antibodies at low pH: From Oligomers to Larger Aggregates , 2012, Pharmaceutical Research.

[16]  S. Y. Gerlsma.  The effects of polyhydric and monohydric alcohols on the heat induced reversible denaturation of chymotrypsinogen A. , 1970, European journal of biochemistry.

[17]  K. Gekko.  Calorimetric study on thermal denaturation of lysozyme in polyol-water mixtures. , 1982, Journal of biochemistry.

[18]  H. Gadgil,et al.  Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc , 2011, The Journal of Biological Chemistry.

[19]  Diwakar Shukla,et al.  Molecular level insight into intra-solvent interaction effects on protein stability and aggregation. , 2011, Advanced drug delivery reviews.

[20]  T. Arakawa,et al.  Mechanisms of protein aggregation. , 2009, Current pharmaceutical biotechnology.

[21]  Christopher J Roberts,et al.  Protein aggregation and its impact on product quality. , 2014, Current opinion in biotechnology.

[22]  Takashi Kumasaka,et al.  High-resolution X-ray analysis reveals binding of arginine to aromatic residues of lysozyme surface: implication of suppression of protein aggregation by arginine. , 2011, Protein engineering, design & selection : PEDS.

[23]  P. Souillac.  Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains. , 2005, Journal of pharmaceutical sciences.

[24]  W. Jiskoot,et al.  Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  D. Ejima,et al.  A novel protein refolding system using lauroyl-l-glutamate as a solubilizing detergent and arginine as a folding assisting agent. , 2011, Protein expression and purification.

[26]  Marisa K Joubert,et al.  Classification and Characterization of Therapeutic Antibody Aggregates , 2011, The Journal of Biological Chemistry.

[27]  S. N. Timasheff,et al.  Preferential solvation of bovine serum albumin in aqueous guanidine hydrochloride. , 1967, The Journal of biological chemistry.

[28]  Frédéric Cardinaux,et al.  Equilibrium cluster formation in concentrated protein solutions and colloids , 2004, Nature.

[29]  Jane Clarke,et al.  Transient misfolding dominates multidomain protein folding , 2015, Nature Communications.

[30]  T. Arakawa,et al.  Multi-faceted arginine: mechanism of the effects of arginine on protein. , 2014, Current protein and peptide science.

[31]  Shunsuke Tomita,et al.  Small Amine Molecules: Solvent Design Toward Facile Improvement of Protein Stability Against Aggregation and Inactivation. , 2015, Current pharmaceutical biotechnology.

[32]  Steven J Shire,et al.  Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. , 2008, Journal of pharmaceutical sciences.

[33]  S. Fujiwara,et al.  Biophysical effect of amino acids on the prevention of protein aggregation. , 2002, Journal of biochemistry.

[34]  María Vázquez-Rey,et al.  Aggregates in monoclonal antibody manufacturing processes , 2011, Biotechnology and bioengineering.

[35]  R. Chou,et al.  Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions. , 2016, Biotechnology advances.

[36]  A. Vermeer,et al.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.